Articles tagged "Kidney transplantation"

2018 American Transplant Congress
Standard- versus Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Kidney Transplant Recipients
N. Wilson, N. Sulejmani, A. Jantz, A. Patel, B. Summers.
Henry Ford Hospital, Detroit, MI.
Background: Although guidelines recommend valganciclovir (VGC) 900 mg daily for cytomegalovirus (CMV) prophylaxis in solid organ transplant patients, multiple centers have reported clinical success, reduced…
2018 American Transplant Congress
Clinical Outcomes of Kidney Transplant Recipients Infected with Hepatitis C Virus and Treated with Direct-Acting Antiviral Therapy
M. Alkadi,¹ E. Abuhelaiqa,¹ M. Derbala,² O. Fituri,¹ J. Mahmoud,³ M. Jarman,³ M. Asim,¹ A. Aziz,¹ A. Nauman,¹ A. Hamdi,¹ Y. Medhat,² S. Al Kaabi,² H. Al-Malki.¹
¹Medicine-Nephrology, Hamad Medical Corporation, Doha, Qatar; ²Medicine-Gastroenterology, Hamad Medical Corporation, Doha, Qatar; ³Surgery-Transplant, Hamad Medical Corporation, Doha, Qatar.
Introduction:Hepatitis C virus (HCV) infection has negative impact on patient and graft survival in kidney transplant recipients. In the past, treatment of HCV infection post…
2018 American Transplant Congress
High Serum Resistin Levels Predict Future Acute Kidney Injury in Kidney Transplantation Patients
M-.C. Lee,^1,3 B-.G. Hsu.^2,3
¹Surgery, Tzu Chi General Hospital, Hualien, Taiwan; ²Nephrology, Tzu Chi General Hospital, Hualien, Taiwan; ³School of Medicine, Tzu Chi University, Hualien, Taiwan.
Introduction:Resistin has a pathogenic role in the development and progression of atherosclerosis. This study was evaluated the association between serum resistin levels and future acute…
2018 American Transplant Congress
Most Pediatric Transplant Centers Are Underperforming and in Proximity to Higher Volume Centers
T. Nichols, A. Rana, J. Goss.
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX.
Purpose. Many research studies have shown that low case volume has been associated with worse survival outcomes in each type of pediatric solid organ transplant.…
2018 American Transplant Congress
Telemedicine Implementation in Organ Transplantation at a Metropolitan Academic Medical Center
D. Tsapepas, H. Li, D. Kohlberg, B. Watts, J. Monteiro, A. Monteiro, N. Jandovitz.
Columbia University / NewYork-Presbyterian Hospital, New York.
Transplant patients represent a complex patient population for which telemedicine may enhance patient access to the healthcare team, patient engagement, patient satisfaction and improved outcomes…
2018 American Transplant Congress
Enhancement of Endogenous omega-3 Protect against Ischemia-Reperfusion Renal Injury in Fat-1 Mice
D. Choi,¹ Y. Ham,¹ K. Na,¹ K. Lee,¹ J-.J. Kim,^1,2 J. Jeong.^1,3
¹Nephrology, Chungnam National University, Daejeon, Korea; ²Biomedical Science, Jungwon University, Chungbuk, Korea; ³Medical Science, Chungnam National University, Daejeong, Korea.
Introduction : Fat-1 transgenic mice produce [omega]3-Polyunsaturated fatty acids ([omega]3-PUFAs) from [omega]6-Polyunsaturated fatty acids ([omega]6-PUFAs) without a dietary [omega]3-PUFAs supplement, leading to a high accumulation…
2018 American Transplant Congress
A New Reality: Virtual Crossmatch Can Be Used Successfully as Pre-Transplant Compatibility Testing for Most Deceased Donor Transplants at a High Volume Center
R. Rajalingam,¹ D. Gae,¹ Z. Laszik,² G. Roll,³ M. Tavakol,³ C. Freise,³ D. Adey,⁴ A. Webber,⁴ D. Dobi,² K. Cunniffe,¹ G. da Gente,¹ N. Ascher,³ P. Stock,³ J. Roberts.³
¹Immunogenetics and Transplantation Laboratory, Dept. of Surgery, UCSF, San Francisco; ²Dept. of Pathology, UCSF, San Francisco; ³Dept. of Surgery, UCSF, San Francisco; ⁴Dept. of Medicine, UCSF, San Francisco.
Aim: We developed a reliable virtual crossmatch (VXM) method for use as pre-transplant XM for deceased donor (DD) kidney transplantation (KTx). Here we report the…
2018 American Transplant Congress
Early Outcomes and Risk Factors after Five Years of a Nationwide Strategy for Kidney Transplantation with Controlled Circulatory Death Donor (cDCD)
J. Portoles,^1,2 M. Perez Saez,² D. Hernandez,² J. Juega,² F. Moreso,² N. Maruri,² P. Lopez,^1,2 E. Melilli,² D. Navarro,² E. de Souza,² J. Ruiz,² M. Mazuecos,² A. Gutierrez,² I. Perez-Flores,² D. Janeiro,^1,2 J. Pascual.²
¹Nephrology, H Puerta de Hierro, Madrid, Spain; ²Nephrology, Spanish Multicentre Sentra-GEODAS Group, Madrid, Spain.
Study: prospective multicentre, systematic inclusion of every kidney transplants-KTx from controlled donation after circulatory death (cDCD) at joined units. Local center surgical and immunosuppressive protocols.Background:…
2018 American Transplant Congress
Safety and Efficacy of Real-World Use of Everolimus for Kidney Transplant Patients: Post-Marketing Surveillance in Japan
H. Harada,¹ Y. Watarai,² J. Uchida,³ O. Kamisawa.⁴
¹Sapporo City General Hospital, Sapporo, Japan; ²Nagoya Daini Red Cross Hospital, Nagaya, Japan; ³Osaka City University, Osaka, Japan; ⁴Novartis Pharma K.K., Tokyo, Japan.
Background and purpose: After the approval of everolimus (EVR) in 2011 in Japan to prevent organ rejection in kidney transplant (KTx) patients, no data on…
2018 American Transplant Congress
Is It Better Choice to Perform Kidney Transplantation for Elderly CKD Patients?
R. Imamura,¹ K. Tsutahara,² K. Yamanaka,³ M. Kawamura,¹ S. Nakazawa,¹ T. Kato,¹ T. Abe,¹ H. Kishikawa,³ N. Ichimaru,⁴ K. Nishimura,³ S. Yamaguchi,² N. Nonomura.¹
¹Urology, Osaka University Graduate School of Medicine, Suita, Japan; ²Urology, Osaka General Medical Center, Osaka, Japan; ³Urology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Japan; ⁴Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Japan.
[Objectives] Japan is forecasted to become an aged society with 30.3% and 39.9% in 2025 and 2060, respectively. Along with that, the number of elderly…